Thermo Fisher Scientific Inc.

TMO · Healthcare · · USD

526.83 USD

+0.00 (0.40%)

● Updated 2026-07-10 17:07 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Mid-term (Position)

/ 100

Technical 75

Trend & RS 68

Momentum 44

Fundamental 78

Macro 71

Liquidity 43

Component	Score	Weight
Technical	75.0	20%
Trend & RS	67.5	30%
Momentum	44.4	15%
Fundamental	77.8	10%
Macro	71.2	20%
Liquidity	42.9	5%

Trade Setup

Entry	527.19
Stop Loss	498.85 (5.4%)
Target 1 (1:1)	555.53 (+5.4%)
Target 2 (2:1)	583.87 (+10.8%)

ATR(14)	14.17 (2.7%)
Risk per Share	28.34
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	56.2	+0.25
Momentum	44.4	-0.22
Quality	42.2	-0.31
Composite	47.6

Quality Scores

Piotroski F-Score 7 /9 — Strong

✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score Insufficient Data

Valuation vs Peers Overvalued

Metric	Stock	Sector	vs Peers
P/E Ratio	28.9	22.0	+32% above
P/B Ratio	3.8	4.0	Inline
Dividend Yield	36.0%	1.5%	Above avg

Comparing against Healthcare median multiples.

Trading at a premium to sector peers — verify growth justifies premium.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

269.11

Market Price

526.83

Upside

-48.9%

Margin of Safety	-95.8%
Stage 1 PV (5yr FCF)	25,052,950,559
Terminal Value PV	74,955,127,335
Total Enterprise Value	100,008,077,894

Assumptions

Base FCF	5,413,781,748
Growth Rate (5yr)	6.2%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.8%

Recommended Size

43.35%

Full Kelly

21.68%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 66/100. Estimated win rate 60%, avg win 9.0%, avg loss 3.7%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

65.1

RSI(14)

13.2043

MACD

Relative Strength (RS) NEUTRAL

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	→ FLAT (-5.5% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (59d since high)
Sector Outperformance	+2.1% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

NEUTRAL: In line with the market — no strong outperformance or underperformance.

Technical Indicators

Indicator	Value	Signal
Rsi	65.1	NEUTRAL
Macd	13.2043	BULLISH
Ma Cross	477.25 / 526.58	DEATH CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.05x	LOW

Key Levels

Level	Price
52-Week High	643.99
Bollinger Upper	542.27
SMA(200)	526.58
SMA(50)	477.25
SMA(20)	495.09
Current Price	526.83
Bollinger Lower	447.92
52-Week Low	403.36
ATR(14)	14.17

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION E Confidence

50%

Acc: 1.0 | Dist: 1.0 | Markup: 0.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-07-06	Normal	0.89x	Normal bar — no special VSA pattern
2026-07-07	Normal	0.65x	Normal bar — no special VSA pattern
2026-07-08	Normal	0.97x	Normal bar — no special VSA pattern
2026-07-09	Normal	0.66x	Normal bar — no special VSA pattern
2026-07-10	No Supply	0.05x	Low volume, narrow spread, firm close — no selling pressure

Ichimoku Cloud BULLISH

Line	Value	Status
Tenkan-sen (9)	512.12	Above Kijun
Kijun-sen (26)	493.39	Base line
Senkou A	502.76	Leading span A
Senkou B	481.99	Leading span B
Cloud	481.99 – 502.76	Bullish (Green)
Price vs Cloud	527.19	Above Cloud
Chikou Span	473.48	Bullish
Alignment Score	4/4	BULLISH